1 / 5

Non-invasive Prenatal Testing Market to Witness Commendable Growth of $6.5 Billion By 2028

As per the published report, the global non invasive prenatal testing market is expected to arrive at USD 6.5 billion, by 2028. It is projected to develop by 10.9% CAGR in the period of 2021 to 2028.

MarketInsights
Download Presentation

Non-invasive Prenatal Testing Market to Witness Commendable Growth of $6.5 Billion By 2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Non-invasive Prenatal Testing Market to Witness Commendable Growth of $6.5 Billion By 2028 “The global non invasive prenatal testing market is expected to arrive at USD 6.5 billion, by 2028. It is projected to develop by 10.9% CAGR in the period of 2021 to 2028.” Global Non Invasive Prenatal Testing Market report delivers future development strategies, key companies, Possibility of competition, major challenges analysis. The reports elaborate the expansion rate of the Non Invasive Prenatal Testing market supported the highest company profile analysis. This report providing an in-depth analysis, market size, and evaluation for the developing segment among the industry. Non Invasive Prenatal Testing Market report will help you take expert decisions, recognize opportunities, plan effective professional tactics, plan new schemes, analyse drivers and restraints and give you a vision on the Non Invasive Prenatal Testing Market forecast. The Non Invasive Prenatal Testing Market report discusses the primary industry growth drivers and challenges that the vendors and the market as a whole face and provides an overview of the key trends emerging in the market. It also talks about the market size of different segments and their growth aspects along with key leading countries in Americas, Asia- Pacific, Europe, the Middle East, and Africa regions. The global non invasive prenatal testing market is expected to arrive at USD 6.5 billion, by 2028. It is projected to develop by 10.9% CAGR in the period of 2021 to 2028. Elevated demand along with the acceptance for before time non invasive prenatal testing, together with the progress in the compensation situation, are some of the factors, inspiring the progress of the market. The exercise of the invasive method of prenatal testing, for example amniocentesis and chorionic villus sampling, can initiate problems, like miscarriage. This has caused to a regression in the exercise of these measures and greater demand for the examinations that are non-invasive, safe and additionally efficient. Request Sample Copy of This Market Research @ https://www.millioninsights.com/industry-reports/global-non-invasive-prenatal-testing-nipt-market/request-sample

  2. Besides, non-invasive fetal tests contain a lesser misleading positive along with failure percentage. This has brought about a substantial rise in acceptance of non-invasive tests, during the previous a small number of years. The non- invasive prenatal testing (NIPT) market is packed with the presented major competitors. The companies are creating joint ventures and associations to retain a steady situation in the market. For example, Eurofins Scientific declared a settlement with Noritsu Koki Co., Ltd. for the acquirement of GeneTech Inc., one of the revolutionary non invasive prenatal testing developing companies of Japan, in August 2020. By way of this acquirement, Eurofins Scientific is ready to reinforce its existence in the Japanese market. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/global-non-invasive-prenatal-testing-nipt-market Further key findings from the report suggest: • One of the important developments pursued by the competitors of the market comprise, authorization of the examination to other labs and making considerable profits, via gathering royalty payments • In 2020, owing to the increasing number of diagnostic laboratories through the world, that gives non invasive prenatal testing; the diagnostic laboratories sector retained the major profits share, with reference to the end use. It will enlarge more, by the highest CAGR, during the forecast period • Due to the existence of constructive compensation strategy in this sector, non invasive prenatal testing for standard & high risk pregnancy, dominated the market • Attributable to the progressively rising standard motherly period and increasing occurrence of chromosomal aneuploidies, Asia Pacific is estimated to record the highest annual enlargement

  3. • Next-Generation Sequencing (NGS) is likely to be the biggest as well as the highest increasing technology division for the forecast period, since the Next-Generation Sequencing is the frequently used technique for non invasive prenatal testing • As a result of the existence of a highest number of examinations, performed in this stage of pregnancy, the 13-24 weeks gestation period sector, held the biggest revenue share, in 2020 Million Insights segmented the global non-invasive prenatal testing market based on End Use, Product, Technology, Method, Gestation Period, Risk Type, and Region. NIPT Gestation Period Outlook (Revenue, USD Million, 2017 - 2028) • 0-12 Weeks • 13-24 Weeks • 25-36 Weeks NIPT Risk Type Outlook (Revenue, USD Million, 2017 - 2028) • High & Average Risk • Low Risk NIPT Method Outlook (Revenue, USD Million, 2017 - 2028) • Ultrasound Detection • Biochemical Screening Tests • Cell-Free DNA in Maternal Plasma Tests NIPT Technology Outlook (Revenue, USD Million, 2017 - 2028) • NGS • Array Technology • PCR • Other Technologies NIPT Product Outlook (Revenue, USD Million, 2017 - 2028) • Consumables & Reagents

  4. • Instruments NIPT End-use Outlook (Revenue, USD Million, 2017 - 2028) • Hospitals & Clinics • Diagnostic Laboratories NIPT Regional Outlook (Revenue, USD Million, 2017 - 2028) • North America • U.S. • Canada • Europe • Germany • U.K. • France • Italy • Spain • Asia Pacific • Japan • China • India • Singapore • Australia • Latin America • Brazil • Mexico • MEA • South Africa • Saudi Arabia Companies Various companies for non-invasive prenatal testing market are: • Quest Diagnostics, Inc. • Qiagen • Myriad Women’s Health, Inc. (Myriad Genetics Inc/Counsyl, Inc.) • Med Genome Labs Ltd. • Illumina, Inc. (Verinata Health, Inc.) • Natera, Inc. • Laboratory Corp. of America Holdings • Progenity, Inc. • F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics) • Eurofins LifeCodexx GmbH • Cento gene N.V. • Genesis Genetics (Cooper Surgical, Inc.)

  5. See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/healthcare Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com Global Headquarters Million Insights 410 E Santa Clara Street, Unit #1008 San Jose,CA 95113, United States Phone: 1-408-610-2300 Email: sales@millioninsights.com Asia Pacific Million Insights Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Phone: 91-8956380892

More Related